RUCDR becomes Infinity BiologiX (IBX)
On June 16th the Rutgers University Board of Governors approved a significant investment for RUCDR by an outside investment firm.
This approval result in a change control of RUCDR to Infinity BiologiX, LLC (IBX), which will be managed both operationally and financially independent of Rutgers University.
IBX continues to operate out of the Rutgers University campus and, along with our 200+ staff of scientists and technicians, we maintain strong scientific and academic links to the University, who remain a stakeholder in the new entity.
Building on a long history, RUCDR has been perfecting the science of biobanking, bioprocessing and analytics since 1999. Access to capital for investment in new technology, infrastructure and resources will enable IBX to grow and capitalize on the unique capabilities of RUCDR.
You can download the full press release on the investment here.
What IBX can offer
The full IBX website will be launching soon, in the mean time you can learn more about our services in the following downloadable brochures, or by visiting the current RUCDR website
